We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Single Blood Test Reveals Biological Ages of Different Organs and Bodily Systems

By LabMedica International staff writers
Posted on 24 Sep 2025

Aging does not occur uniformly across the body. More...

While some organs may age rapidly, others remain healthier for longer due to lifestyle, environmental, and genetic factors. Traditional biological age tests, such as epigenetic clocks, provide only a single number and fail to show which body systems are most at risk. Scientists have now created a more advanced test capable of assessing aging across multiple physiological systems with greater precision.

Researchers from Yale University (New Haven, CT, USA) described this new approach, called the Systems Age test, in the journal Nature Aging. Developed using data from over 7,500 people, the test combines blood-based biomarkers such as cholesterol and blood sugar with DNA methylation patterns to provide system-specific biological age scores. By training machine learning models, the team designed a single blood test that can measure aging in 11 systems, including the heart, lungs, brain, metabolism, and immune system.

To validate their method, scientists tested the model on blood samples from more than 8,000 individuals. The results showed it predicted age-related diseases more effectively than older epigenetic clocks. For example, the heart score from the new test was a stronger predictor of heart disease compared to standard biological age measures, demonstrating the tool’s superior diagnostic accuracy.

The findings also revealed significant variability in aging patterns across individuals. People with the same overall biological age often showed different rates of aging across organs. This insight could help doctors identify which systems are most vulnerable and deliver more personalized strategies for prevention and treatment, ranging from lifestyle changes to targeted therapies.

“By providing system-specific scores, Systems Age may better pinpoint which age-related conditions individuals are at risk for,” wrote study author Morgan Levine.

Related Links:
Yale University


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.